Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$25.32 - $51.45 $354,480 - $720,300
14,000 New
14,000 $513,000
Q3 2021

Nov 15, 2021

SELL
$84.7 - $96.31 $15 Million - $17.1 Million
-177,322 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$76.44 - $89.57 $13.1 Million - $15.4 Million
-171,779 Reduced 49.21%
177,322 $15.9 Million
Q1 2021

May 17, 2021

BUY
$67.36 - $80.76 $1.74 Million - $2.08 Million
25,776 Added 7.97%
349,101 $26.5 Million
Q4 2020

Feb 12, 2021

SELL
$53.08 - $69.86 $16.1 Million - $21.2 Million
-303,333 Reduced 48.4%
323,325 $22 Million
Q3 2020

Nov 09, 2020

BUY
$51.29 - $65.09 $32.1 Million - $40.8 Million
626,658 New
626,658 $33.3 Million

Others Institutions Holding SYNH

About Syneos Health, Inc.


  • Ticker SYNH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,653,000
  • Description
  • Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...
More about SYNH
Track This Portfolio

Track Caas Capital Management LP Portfolio

Follow Caas Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caas Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Caas Capital Management LP with notifications on news.